Viking Therapeutics Inc (VKTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.73B
Last updated: Nov 17, 2026 at 11:05 AM ET
Viking Therapeutics Inc (VKTX) Competitors
The companies most similar to Viking Therapeutics are Viridian Therapeutics (VRDN), Travere Therapeutics (TVTX) and Vera Therapeutics (VERA). By market cap, Viking Therapeutics ranks 4th of the 13 companies on this page; Edgewise Therapeutics (EWTX) is the largest at $5.03B.
Peer Comparison
VKTX's ROIC of -61.0% is below the peer median of -32.4%, and its revenue growth of 0.0% is below the median of 11.2%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Viking Therapeutics (VKTX) | $3.73B | N/A | N/A | 0.0% | -61.0% | 0.0% | 0.00% |
| Viridian Therapeutics Inc (VRDN) | $3.51B | N/A | 128.5x | 0.0% | -41.8% | -63.5% | 0.00% |
| Travere Therapeutics Inc (TVTX) | $4.86B | N/A | 7.2x | -18.7% | -23.1% | 36.2% | 0.00% |
| Vera Therapeutics Inc (VERA) | $2.03B | N/A | 189.3x | 0.0% | -83.0% | 0.0% | 0.00% |
| Legend Biotech Corp (LEGN) | $3.39B | 266.5x | 2.3x | -0.0% | N/A | 32.0% | 0.00% |
| Denali Therapeutics Inc (DNLI) | $3.00B | N/A | 159.3x | 0.0% | N/A | -100.0% | 0.00% |
| Xenon Pharmaceuticals Inc (XENE) | $3.98B | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Vericel Corp Ord (VCEL) | $2.91B | 89.8x | 9.1x | 10.3% | N/A | 26.5% | 0.00% |
| Telix Pharmaceuticals Limited (TLX) | $3.14B | N/A | 5.3x | 3.8% | -0.7% | 22.3% | 0.00% |
| Vir Biotechnology Inc (VIR) | $1.71B | N/A | 5.4x | -61.0% | N/A | 19582.0% | 0.00% |
| Iovance Biotherapeutics Inc (IOVA) | $3.59B | N/A | 9.1x | -58.2% | N/A | 80.1% | 0.00% |
| Edgewise Therapeutics Inc (EWTX) | $5.03B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Trevi Therapeutics Inc (TRVI) | $1.95B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $3.27B | 178.2x | 9.1x | 0.0% | -32.4% | 11.2% | 0.00% |
Similar Companies
These are the 12 companies most similar to Viking Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Viridian Therapeutics Inc (VRDN) | Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses. | VRDN competitors |
| Travere Therapeutics Inc (TVTX) | Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification... | TVTX competitors |
| Vera Therapeutics Inc (VERA) | Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases... | VERA competitors |
| Legend Biotech Corp (LEGN) | Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology... | LEGN competitors |
| Denali Therapeutics Inc (DNLI) | Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. | DNLI competitors |
| Xenon Pharmaceuticals Inc (XENE) | Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders... | XENE competitors |
| Vericel Corp Ord (VCEL) | Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures... | VCEL competitors |
| Telix Pharmaceuticals Limited (TLX) | Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic... | |
| Vir Biotechnology Inc (VIR) | Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. | VIR competitors |
| Iovance Biotherapeutics Inc (IOVA) | Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness... | IOVA competitors |
| Edgewise Therapeutics Inc (EWTX) | Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. | EWTX competitors |
| Trevi Therapeutics Inc (TRVI) | Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the development and commercialization of Haduvio to treat serious... | TRVI competitors |
Frequently Asked Questions About VKTX
Who are Viking Therapeutics' main competitors?
The companies most similar to Viking Therapeutics include Viridian Therapeutics (VRDN), Travere Therapeutics (TVTX), Vera Therapeutics (VERA), Legend Biotech (LEGN) and Denali Therapeutics (DNLI), listed from the closest match.
Who is Viking Therapeutics' biggest competitor?
Edgewise Therapeutics (EWTX) is the largest of the similar companies at $5.03B; Viridian Therapeutics (VRDN) is the closest match by business profile, size, sector and industry.
How does VKTX stock compare with its competitors?
VKTX's net margin is 0.0% against a peer median of 0.0%.
Which of Viking Therapeutics' competitors pays a higher dividend?
Viking Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Viking Therapeutics bigger than its competitors?
No. Viking Therapeutics is 4th by market cap among the 13 companies on this page; the largest is Edgewise Therapeutics (EWTX) at $5.03B.
VKTX pages: Overview, Earnings, Forecast, Financials, Competitors